U.S. Food and Drug Administration Development & Approval Process for Drugs
U.S. Food and Drug Administration (FDA) resource about the development and approval of new drugs.
Category: Medical ethics
“The right to a trial”
Dec. 18, 2006, The New Yorker article by Dr. Jerome Groopman about the Abigail Alliance case.
Dr. Sidney Wolfe
Dr. Sidney Wolfe is a senior adviser and co-founder of the Health Research Group, one of Public Citizen’s five policy groups. Public Citizen is a nonprofit public interest group in Washington, D.C. Contact Angela Bradbery, director of communications.
Kenneth Kaitin
Kenneth Kaitin is director of the Tufts Center for the Study of Drug Development in Boston.
Scott Ballenger
Scott Ballenger is founder of the Trial Acceleration Institute in Spring House, Pa., which assists stakeholders in speeding up clinical trials.
Frank Palumbo
Frank Palumbo is a professor and director of the Center on Drugs and Public Policy at the University of Maryland School of Pharmacy in Baltimore.
“New report finds uneven progress in expanding pregnancy and delivery care in the developing world”
Read a Guttmacher Institute study published May 28, 2013.
Ira Byock
Dr. Ira Byock is the executive director and chief medical officer for the Providence Institute for Human Caring. He was formerly the director of the palliative care program at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. His books include Dying Well: Peace and Possibilities at the End of Life. A past president of the American Academy of Hospice and Palliative Medicine, […]
Carl E. Schneider
Carl E. Schneider is Chauncey Stillman Professor for Ethics, Morality and the Practice of Law at the University of Michigan Law School. He served on the President’s Council on Bioethics and edited Law at the End of Life: The Supreme Court and Assisted Suicide.